JP2023521491A5 - - Google Patents
Info
- Publication number
- JP2023521491A5 JP2023521491A5 JP2022562985A JP2022562985A JP2023521491A5 JP 2023521491 A5 JP2023521491 A5 JP 2023521491A5 JP 2022562985 A JP2022562985 A JP 2022562985A JP 2022562985 A JP2022562985 A JP 2022562985A JP 2023521491 A5 JP2023521491 A5 JP 2023521491A5
- Authority
- JP
- Japan
- Prior art keywords
- cysteine
- glutamine
- lysine
- alanine
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20200047733 | 2020-04-20 | ||
| KR10-2020-0047733 | 2020-04-20 | ||
| PCT/KR2021/004961 WO2021215801A1 (ko) | 2020-04-20 | 2021-04-20 | 글루카곤, glp-1 및 gip 수용체 모두에 활성을 갖는 삼중 활성체 또는 이의 결합체를 포함하는 고지혈증 예방 또는 치료용 약학적 조성물 및 예방 또는 치료 방법 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023521491A JP2023521491A (ja) | 2023-05-24 |
| JP2023521491A5 true JP2023521491A5 (https=) | 2024-05-07 |
Family
ID=78232790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562985A Pending JP2023521491A (ja) | 2020-04-20 | 2021-04-20 | グルカゴン、ｇｌｐ－１及びｇｉｐ受容体の全てに対して活性を有する三重活性体又はその結合体を含む高脂血症の予防又は治療用薬学的組成物及び予防又は治療方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230158117A1 (https=) |
| EP (1) | EP4140496A4 (https=) |
| JP (1) | JP2023521491A (https=) |
| KR (1) | KR20210129614A (https=) |
| CN (1) | CN115916238A (https=) |
| AU (1) | AU2021203645B2 (https=) |
| BR (1) | BR112022020531A2 (https=) |
| CA (1) | CA3174423A1 (https=) |
| IL (1) | IL296960A (https=) |
| MX (1) | MX2022012847A (https=) |
| TW (1) | TW202203963A (https=) |
| WO (1) | WO2021215801A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230095665A (ko) * | 2021-12-22 | 2023-06-29 | 한미약품 주식회사 | 간 표적 약물 및 이의 용도 |
| KR20250177375A (ko) * | 2024-06-13 | 2025-12-23 | 한미약품 주식회사 | Glp-1, gip, 및 글루카곤 수용체 모두에 활성을 갖는 삼중 활성체 및 이를 포함하는 지질 대사 질환 예방 또는 치료용 약학적 조성물 |
| WO2026082095A1 (en) * | 2024-10-17 | 2026-04-23 | Innovent Biologics (Suzhou) Co., Ltd. | Compounds for treating metabolic disorders |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| JP4046354B2 (ja) | 1996-03-18 | 2008-02-13 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | 増大した半減期を有する免疫グロブリン様ドメイン |
| EP1667724A2 (en) * | 2003-09-19 | 2006-06-14 | Novo Nordisk A/S | Albumin-binding derivatives of therapeutic peptides |
| JP2009534423A (ja) * | 2006-04-20 | 2009-09-24 | アムジェン インコーポレイテッド | Ｇｌｐ−１化合物 |
| AU2013366692B2 (en) * | 2012-12-21 | 2017-11-23 | Sanofi | Dual GLP1/GIP or trigonal GLP1/GIP/Glucagon agonists |
| CN105829339B (zh) * | 2013-11-06 | 2021-03-12 | 西兰制药公司 | 胰高血糖素-glp-1-gip三重激动剂化合物 |
| SG11201805586SA (en) * | 2015-12-31 | 2018-07-30 | Hanmi Pharmaceutical Co Ltd | Triple glucagon/glp-1/gip receptor agonist |
| EP3479841A4 (en) * | 2016-06-29 | 2020-03-04 | Hanmi Pharm. Co., Ltd. | GLUCAGON DERIVATIVE, CONJUGATE THEREOF, COMPOSITION THEREOF AND THERAPEUTIC USE THEREOF |
| TW201833131A (zh) * | 2016-12-02 | 2018-09-16 | 法商賽諾菲公司 | 作為胜肽類ｇｌｐ１／升糖素／ｇｉｐ受體促效劑之新化合物 |
| SG11202001283PA (en) * | 2017-08-16 | 2020-03-30 | Dong A St Co Ltd | Acylated oxyntomodulin peptide analog |
-
2021
- 2021-04-20 EP EP21793803.4A patent/EP4140496A4/en active Pending
- 2021-04-20 CN CN202180038989.3A patent/CN115916238A/zh active Pending
- 2021-04-20 TW TW110114173A patent/TW202203963A/zh unknown
- 2021-04-20 JP JP2022562985A patent/JP2023521491A/ja active Pending
- 2021-04-20 IL IL296960A patent/IL296960A/en unknown
- 2021-04-20 KR KR1020210051337A patent/KR20210129614A/ko active Pending
- 2021-04-20 CA CA3174423A patent/CA3174423A1/en active Pending
- 2021-04-20 WO PCT/KR2021/004961 patent/WO2021215801A1/ko not_active Ceased
- 2021-04-20 MX MX2022012847A patent/MX2022012847A/es unknown
- 2021-04-20 BR BR112022020531A patent/BR112022020531A2/pt unknown
- 2021-04-20 AU AU2021203645A patent/AU2021203645B2/en active Active
- 2021-04-20 US US17/917,846 patent/US20230158117A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019504057A5 (https=) | ||
| JP2019504055A5 (https=) | ||
| JP2023521491A5 (https=) | ||
| ES2514615T3 (es) | Proteínas de dominio Kunitz inhibidores de calicreína y ácidos nucleicos que codifican las mismas | |
| PE20250556A1 (es) | Agonista triple de receptores de glucagon/glp-1/gip | |
| WO2019085772A1 (zh) | 基于胃泌酸调节素类似物glp-1r/gcgr双靶点激动剂多肽治疗胆汁性肝硬化 | |
| AR038102A1 (es) | Analogos extendidos de peptido 1 de tipo glucagon | |
| US20130023471A1 (en) | Methods to restore glycemic control | |
| CA2412004A1 (en) | Glucagon-like peptide-1 analogs | |
| CA2356331C (en) | Methods for glucagon suppression | |
| CA2434237A1 (en) | Glp-1 fusion proteins | |
| PE20231309A1 (es) | Agonistas duales glp-1/gip | |
| CA2320371A1 (en) | Inotropic and diuretic effects of exendin and glp-1 | |
| CA2309356A1 (en) | Novel exendin agonist compounds | |
| JP2008500281A5 (https=) | ||
| AU2015321161A1 (en) | Oxyntomodulin analogue | |
| JP2016521253A (ja) | 持続性作用を有するプロドラッグ | |
| WO2013110069A1 (en) | Glutamic acid-stabilized insulin analogues | |
| Ku et al. | DPP4 deficiency preserves cardiac function via GLP-1 signaling in rats subjected to myocardial ischemia/reperfusion | |
| WO2016105545A2 (en) | Insulin analogues with enhanced stabilized and reduced mitogenicity | |
| CN106661096A (zh) | 新的艾塞那肽类似物及其用途 | |
| KR101404561B1 (ko) | Ｖｉｐ 단편 및 사용 방법 | |
| JP2023027315A (ja) | 副甲状腺ホルモン融合ポリペプチド | |
| US20230118307A1 (en) | Therapeutic use of long-acting conjugate of triple agonist having activities to all of glucagon/glp-1/gip receptors for lung disease | |
| WO2019085773A1 (zh) | 基于胃泌酸调节素类似物glp-1r/gcgr双靶点激动剂多肽治疗特发性肺间质纤维化 |